|Email Newsletters from Pharmaceutical Technology and Pharmaceutical Technology Europe|
News from Europe's pharmaceutical manufacturing industry coupled with upcoming events, and exclusive articles and interviews from industry experts.
Industry Briefs: May 21, 2012
Avalanche Biotechnologies and Lonza have formed a manufacturing collaboration focused on process development and scale-up efforts for the manufacturing of adeno-associated viral vectors for gene therapy. Read More
GlaxoSmithKline has completed the transaction to increase its ownership in the biopharmaceutical company Theravance. Read More
Lubrizol has formed LifeScience Polymers, a new product line created for the delivery of polymer technologies and solutions to the pharmaceutical and healthcare markets.
Marina Biotech and Girindus Group have formed a development, supply, and commercialization pact for oligonucleotide constructs. Read More
Mitsubishi Tanabe has announced plans to transfer its fine-chemical operations to two companies and withdraw from the fine-chemical industry. Read More
Piramal Healthcare has agreed to acquire Decision Resources Group, a healthcare information management company, for approximately $635 million. Read More
Shimadzu has added a triple quadrupole gas chromatograph mass spectrometer and has also expanded its LC–MS/MS product portfolio. Read More
AMRI has appointed Ian Shott as president of AMRI Europe. Read More
BASi has named David Reynolds as its director of discovery systems. Read More
Camargo has appointed K. Gary Barnette as vice-president of drug development. Read More
Teva’s board of directors has voted to re-elect Phillip Frost as chairman of the board. Read More